Retrospective Study of 13 Unsuccessful Remission Cases among 53 Patients with Acute Leukemia.
10.2185/jjrm.46.135
- VernacularTitle:当院の急性白血病の寛解導入不能例の検討
- Author:
Toru TAKAHASHI
;
Masato HAYASHI
;
Akira MIURA
- Publication Type:Journal Article
- Keywords:
Granulocyte colony-stimulating factor
- From:Journal of the Japanese Association of Rural Medicine
1997;46(2):135-141
- CountryJapan
- Language:Japanese
-
Abstract:
We performed a retrospective study on the clinical data of 13 remission failure cases in 53 patients who had received remission induction therapy for acute leukemia (AL) in our hospital over the past seven years.
The outstanding clinical manifestations of the remission failure cases, as compared with the successful cases, included (a) disseminated intravascular coagulation (DIC) syndrome (b) complex chromosomal abnormalities (c) leukocytosis over 100, 000/μl and (d) markedly elevated seum LDH level and thymidine kinase activitis at the time of initial admission.
The greater majority of these cases (10 out of 13) resulted in death within 90 days after the start of induction therapy.
The causes of death were predominantly hemorrhagic events associated with DIC syndrome, cerebral hemorrhage and severe infectious diseases such as sepsis and pneumonia.
Earlier death within 14 days after therapy was caused from hemorrhagic events and later one was severe infections.
In the G-CSF treated group, the febril term of over 38°C was shorter and the number of days taken for the neutrophil counts to be restored to the 1, 000/μl level was fewer than in the non G-CSF treated group.
Thus, it was suggested that G-CSF was expected to be one of the useful supporting agents to prevent infections in remission induction therapy for acute leukemia.
